These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27254664)

  • 21. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo.
    Hicks AN; Lorenzetti D; Gilley J; Lu B; Andersson KE; Miligan C; Overbeek PA; Oppenheim R; Bishop CE
    PLoS One; 2012; 7(10):e47869. PubMed ID: 23082226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
    Summers DW; Milbrandt J; DiAntonio A
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HSP90 chaperone machinery.
    Schopf FH; Biebl MM; Buchner J
    Nat Rev Mol Cell Biol; 2017 Jun; 18(6):345-360. PubMed ID: 28429788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both the N- and C-terminal chaperone sites of Hsp90 participate in protein refolding.
    Minami M; Nakamura M; Emori Y; Minami Y
    Eur J Biochem; 2001 Apr; 268(8):2520-4. PubMed ID: 11298772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two for the Price of One: A Neuroprotective Chaperone Kit within NAD Synthase Protein NMNAT2.
    Lavado-Roldán A; Fernández-Chacón R
    PLoS Biol; 2016 Jul; 14(7):e1002522. PubMed ID: 27454736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
    Ota A; Zhang J; Ping P; Han J; Wang Y
    Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.
    Slivicki RA; Ali YO; Lu HC; Hohmann AG
    PLoS One; 2016; 11(1):e0147620. PubMed ID: 26808812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system.
    Brychzy A; Rein T; Winklhofer KF; Hartl FU; Young JC; Obermann WM
    EMBO J; 2003 Jul; 22(14):3613-23. PubMed ID: 12853476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotinamide mononucleotide adenylyltransferase uses its NAD
    Ma X; Zhu Y; Lu J; Xie J; Li C; Shin WS; Qiang J; Liu J; Dou S; Xiao Y; Wang C; Jia C; Long H; Yang J; Fang Y; Jiang L; Zhang Y; Zhang S; Zhai RG; Liu C; Li D
    Elife; 2020 Apr; 9():. PubMed ID: 32250733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co-chaperone STI1.
    Lackie RE; Razzaq AR; Farhan SMK; Qiu LR; Moshitzky G; Beraldo FH; Lopes MH; Maciejewski A; Gros R; Fan J; Choy WY; Greenberg DS; Martins VR; Duennwald ML; Lerch JP; Soreq H; Prado VF; Prado MAM
    J Neurochem; 2020 Jun; 153(6):727-758. PubMed ID: 31562773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMNAT2 is a druggable target to drive neuronal NAD production.
    Tribble JR; Jöe M; Varricchio C; Otmani A; Canovai A; Habchi B; Daskalakis E; Chaleckis R; Loreto A; Gilley J; Wheelock CE; Jóhannesson G; Wong RCB; Coleman MP; Brancale A; Williams PA
    Nat Commun; 2024 Jul; 15(1):6256. PubMed ID: 39048544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinamide Mononucleotide Adenylyl Transferase 2: A Promising Diagnostic and Therapeutic Target for Colorectal Cancer.
    Cui C; Qi J; Deng Q; Chen R; Zhai D; Yu J
    Biomed Res Int; 2016; 2016():1804137. PubMed ID: 27218101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship.
    Brunetti L; Di Stefano M; Ruggieri S; Cimadamore F; Magni G
    Protein Sci; 2010 Dec; 19(12):2440-50. PubMed ID: 20954240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.
    Milde S; Fox AN; Freeman MR; Coleman MP
    Sci Rep; 2013; 3():2567. PubMed ID: 23995269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
    Bohush A; Bieganowski P; Filipek A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain.
    Taguchi J; Fujii A; Fujino Y; Tsujioka Y; Takahashi M; Tsuboi Y; Wada I; Yamada T
    Acta Neuropathol; 2000 Aug; 100(2):153-60. PubMed ID: 10963362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding.
    Freeman BC; Morimoto RI
    EMBO J; 1996 Jun; 15(12):2969-79. PubMed ID: 8670798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Hsp90 in protein complex assembly.
    Makhnevych T; Houry WA
    Biochim Biophys Acta; 2012 Mar; 1823(3):674-82. PubMed ID: 21945180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMNAT2: An important metabolic enzyme affecting the disease progression.
    Li W; Gao M; Hu C; Chen X; Zhou Y
    Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.